These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 837512)

  • 1. Platelet survival time in patients with hypoxemia and pulmonary hypertension.
    Steele P; Ellis JH; Weily HS; Genton E
    Circulation; 1977 Apr; 55(4):660-1. PubMed ID: 837512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-mediated pulmonary hypertension and hypoxia during pulmonary microembolism: reduction by platelet inhibition.
    Mlczoch J; Tucker A; Weir EK; Reeves JT; Grover RF
    Chest; 1978 Dec; 74(6):648-53. PubMed ID: 738122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of clofibrate and sulfinpyrazone on platelet survival time in coronary artery disease.
    Steele P; Battock D; Genton E
    Circulation; 1975 Sep; 52(3):473-6. PubMed ID: 1157247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelets in rats with chronic normobaric hypoxic pulmonary hypertension.
    Kentera D; Zdravković M; Rolović Z; Susić D
    Respiration; 1985; 48(2):159-63. PubMed ID: 4059671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of pulse oximeters in detecting hypoxemia in patients with chronic thromboembolic pulmonary hypertension.
    Kohyama T; Moriyama K; Kanai R; Kotani M; Uzawa K; Satoh T; Yorozu T
    PLoS One; 2015; 10(5):e0126979. PubMed ID: 25978517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe Pulmonary Arteriopathy Is Associated with Persistent Hypoxemia after Pulmonary Endarterectomy in Chronic Thromboembolic Pulmonary Hypertension.
    Jujo T; Tanabe N; Sakao S; Ishibashi-Ueda H; Ishida K; Naito A; Kato F; Takeuchi T; Sekine A; Nishimura R; Sugiura T; Shigeta A; Masuda M; Tatsumi K
    PLoS One; 2016; 11(8):e0161827. PubMed ID: 27571267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet suppressant therapy in patients with prosthetic cardiac valves. Relationship of clinical effectiveness to alteration of platelet survival time.
    Steele P; Rainwater J; Vogel R
    Circulation; 1979 Oct; 60(4):910-3. PubMed ID: 476893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of sulfinpyrazone on platelet survival time in patients with transient cerebral ischemic attacks.
    Steele P; Carroll J; Overfield D; Genton E
    Stroke; 1977; 8(3):396-8. PubMed ID: 871029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary hypertension and cardiac function in adult cystic fibrosis: role of hypoxemia.
    Fraser KL; Tullis DE; Sasson Z; Hyland RH; Thornley KS; Hanly PJ
    Chest; 1999 May; 115(5):1321-8. PubMed ID: 10334147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac output, pulmonary hypertension, hypoxaemia and survival in patients with chronic obstructive airways disease.
    Finlay M; Middleton HC; Peake MD; Howard P
    Eur J Respir Dis; 1983 May; 64(4):252-63. PubMed ID: 6861920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement in pulmonary hypertension and hypoxemia during nitric oxide inhalation in a patient with end-stage pulmonary fibrosis.
    Channick RN; Hoch RC; Newhart JW; Johnson FW; Smith CM
    Am J Respir Crit Care Med; 1994 Mar; 149(3 Pt 1):811-4. PubMed ID: 8118653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of platelet survival time with oxygen in patients with chronic obstructive airway disease.
    Johnson TS; Ellis JH; Steele PP
    Am Rev Respir Dis; 1978 Feb; 117(2):255-7. PubMed ID: 637408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-mediated pulmonary hypertension: reduction by platelet inhibition.
    Mlczoch J; Reeves JT; Grover RF
    Prog Biochem Pharmacol; 1977; 13():344-8. PubMed ID: 928435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary hypertension secondary to minor pulmonary embolism.
    Alpert JS; Godtfredsen J; Ockene IS; Anas J; Dalen JE
    Chest; 1978 Jun; 73(6):795-7. PubMed ID: 657852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of inhaled nitric oxide in patients with hypoxemia and pulmonary hypertension after cardiac surgery.
    Bender KA; Alexander JA; Enos JM; Skimming JW
    Am J Crit Care; 1997 Mar; 6(2):127-31. PubMed ID: 9172849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of platelets in the development and progression of pulmonary arterial hypertension.
    Kazimierczyk R; Kamiński K
    Adv Med Sci; 2018 Sep; 63(2):312-316. PubMed ID: 29885631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of intentional hemodilution on platelet survival in secondary pulmonary hypertension.
    Lopes AA; Maeda NY; Ebaid M; Chamone DF; Pileggi F
    Chest; 1989 Jun; 95(6):1207-10. PubMed ID: 2721253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet inhibition in the management of thrombosis.
    Didisheim P; Kazmier FJ; Fuster V
    Thromb Diath Haemorrh; 1974 Sep; 32(1):21-34. PubMed ID: 4616423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxic pulmonary hypertension: changes in platelet size and number.
    Segall M; Goetzman B
    Am J Perinatol; 1991 Sep; 8(5):300-3. PubMed ID: 1760062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet survival time in severe chronic airway obstruction.
    Steele P; Ellis JH; Genton E
    Chest; 1975 Feb; 67(2 Suppl):46S-47S. PubMed ID: 1112110
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.